Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Sorafenib 20 lenvatinib 18 Hepatectomy 17 Blood Specimen Collection 12 Immune Checkpoint Inhibitors 11 atezolizumab 9 Liver Transplantation 9 Surgical Procedures, Operative 7 Radiofrequency Ablation 7 Observation 7 Bevacizumab 7 regorafenib 5 gadolinium ethoxybenzyl DTPA 5 sintilimab 4 donafenib 4 camrelizumab 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 tislelizumab 3 spartalizumab 3 Polymerase Chain Reaction 3 Neoadjuvant Therapy 3 Mass Spectrometry 3 Immunohistochemistry 3 Doxorubicin 3 Angiogenesis Inhibitors 3 toripalimab 2 pembrolizumab 2 entecavir 2 apatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Hepatocellular × Amphotericin B × Clear all

NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

40,110 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡